SavedAdd your journal

Journals / Çocuk Enfeksiyon Dergisi / 2011 / Cilt: 5 - Sayı: 2

İnvaziv Pulmoner Aspergillozis Enfeksiyonu Sırasında Zigomikoz Gelişen Ağır Aplastik Anemili Olguda Lipozomal Amfoterisin B Allerjisi ve Desensitizasyon

Deniz ÇAKIR
Pages
88–89
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
🔖

Cite This Article

ÇAKIR, D. (2011). İnvaziv Pulmoner Aspergillozis Enfeksiyonu Sırasında Zigomikoz Gelişen Ağır Aplastik Anemili Olguda Lipozomal Amfoterisin B Allerjisi ve Desensitizasyon. Çocuk Enfeksiyon Dergisi, Cilt: 5 - Sayı: 2, 88–89. https://ajindex.com/articles/210753

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (8)

  1. Ay Y, Yılmaz D, Balkan C. İnvaziv Pulmoner Aspergillozis Enfeksiyonu Sırasında Zigomikoz Gelişen Ağır Aplastik Anemili Olguda Lipozomal Amfoterisin B Allerjisi ve Desensitizasyon. J Pediatr Inf 2011; 5: 22-5.
  2. Starke JR, Mason EO Jr, Kramer WG, Kaplan SL. Pharmacokinetics of amphotericin B in infants and children. J Infect Dis 1987; 155: 766-74.
  3. E. Roilides, T. E. Zaoutis, T. J. Walsh. Invasive zygomycosis in neonates and children. Clin Microbiol Infect 2009; 15 (Suppl. 5): 50-4.
  4. Groll AH, Walsh TJ, Antifungal Agents. In: Feigin RD, Cherry JD (eds). Textbook of Pediatric Infectious Diseases. 6th Edition. Philadelphia: Saunders; 2009. p.3287-8. US Food and Drug Administration. Noxafil_ (posaconazole) oral suspension. http://www.accessdata.fda.gov/scripts/cder/drugsatfda/ index.cfm?fuseaction=search.label_ApprovalHistory [Erişim Tarihi 10.04.2011].
  5. Van Burik JA, Hare RS, Solomon HF, Corrado ML, Kontoyiannis DP. Posaconazole is effective as salvage therapy in zygomycosis: a retrospective summary of 91 cases.Clin Infect Dis 2006; 42: 61-5.
  6. Greenbury RN, Mullane K, van Burik JA et al. Posaconazole as salvage therapy for zygomycosis. Antimicrob Agents Chemother 2006; 50: 126-33.
  7. Luna B, Drew RH, Perfect JR: Agents for treatment of invasive fungal infections. Otolaryngol Clin North Am 2000; 33: 277-99.
  8. Pitisuttithum P, Negroni R, Graybill JR, et al: Activity of posaconazole in the treatment of central nervous system fungal infections. J Antimicrob Chemother 2005; 56: 745-55.